| Estonia | | |
Time spent for sleeping (men and women, minutes per day per person) | 530.0 (2009/10) [2/30countries] | | | Time spent for sleeping (men, minutes per day per person) | 531.8 (2009/10) [1/30countries] | | | Time spent for sleeping (women, minutes per day per person) | 527.8 (2009/10) [3/30countries] | | |
|
| Estonia | | |
Time spent for eating and drinking (men and women, minutes per day per person) | 79.0 (2009/10) [25/30countries] | | | Time spent for eating and drinking (men, minutes per day per person) | 82.0 (2009/10) [20/30countries] | | | Time spent for eating and drinking (women, minutes per day per person) | 76.8 (2009/10) [27/30countries] | | |
|
| Estonia | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 29.7% (2020) [9/38countries] | | |
|
| Estonia | | |
New HIV infections (per 1000 uninfected population) | 0.16 (2020) [4/19countries] | | | Tuberculosis incidence (per 100,000 population) | 9.3 (2021) [12/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.3 (2020) [8/38countries] | | | Reported number of people requiring interventions against NTDs | 0 (2021) [25/34countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 14.9 (2019) [8/38countries] | | |
|
| Estonia | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 278.5 (2020) [24/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 9.4 (2020) [23/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 5.3 (2020) [22/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 63.0 (2020) [31/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 18.5 (2020) [2/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 72.4 (2020) [17/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 15.4 (2020) [15/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.6 (2020) [20/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 13.7 (2020) [3/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 2.5 (2020) [13/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 8.7 (2020) [8/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 3.0 (2020) [27/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 4.4 (2020) [26/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 26.7 (2020) [22/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 15.9 (2020) [24/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 2.8 (2020) [24/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.4 (2020) [12/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 11.1 (2020) [20/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 2.9 (2020) [22/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.2 (2020) [28/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 10.3 (2020) [7/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 8.9 (2020) [6/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 102.1 (2020) [2/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.3 (2020) [8/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 3.2 (2020) [35/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 4.7 (2020) [37/38countries] | | |
|
| Estonia | | |
Suicide, age-standardized (per 100 000 population) | 11.96 (2019) [10/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 20.16 (2019) [6/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 4.49 (2019) [20/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 14.64 (2019) [3/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 21.22 (2019) [4/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 7.72 (2019) [5/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 12.11 (2019) [16/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 19.45 (2019) [16/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.96 (2019) [18/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 13.48 (2019) [15/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 21.95 (2019) [12/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.51 (2019) [22/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 13.23 (2019) [30/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 22.47 (2019) [25/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 4.09 (2019) [31/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 24.49 (2019) [7/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 45.22 (2019) [5/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 6.86 (2019) [23/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 24.39 (2019) [4/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 47.95 (2019) [4/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 8.74 (2019) [15/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 21.83 (2019) [14/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 39.07 (2019) [14/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 14.03 (2019) [10/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 33.09 (2019) [8/38countries] | | |
|
|